HOXA13 Is a Potential GBM Diagnostic Marker and Promotes Glioma Invasion by Activating the WNT and TGF-β Pathways
Oncotarget - United States
doi 10.18632/oncotarget.4813
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2015
Authors
Publisher
Impact Journals, LLC